[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":8130000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1748000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":861000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":945000.0,"OperatingIncomeLoss_3_Q3_USD":-81660000.0,"OperatingIncomeLoss_1_Q3_USD":-24583000.0,"OperatingExpenses_3_Q3_USD":81660000.0,"OperatingExpenses_1_Q3_USD":24583000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"OtherAssetsNoncurrent_0_Q3_USD":0.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"NetIncomeLoss_1_Q3_USD":-24551000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-76125000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":80202000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":109429000.0,"LiabilitiesCurrent_0_Q3_USD":20443000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":247790000.0,"Liabilities_0_Q3_USD":21304000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":184000.0,"NetIncomeLoss_3_Q3_USD":-81489000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-14000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-10000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-13000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":97370000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":105217000.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q3_USD":1095000.0,"StockholdersEquity_0_Q3_USD":226486000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":6997000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-646562000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":59972000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":17935000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":136447000.0,"ProceedsFromIncomeTaxRefunds_3_Q3_USD":1765000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4070000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":56245000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":42000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":105217000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-726000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_3_Q3_USD":-449000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":113506000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":179879000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":179879000.0,"Cash_0_Q3_USD":97000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":62091000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":62102000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":11000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":0.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":82900000.0,"AssetsCurrent_0_Q3_USD":246040000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":10992000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":10992000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":6997000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2626000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2626000.0,"AdditionalPaidInCapital_0_Q3_USD":872955000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-11000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-918000.0,"Assets_0_Q3_USD":247790000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":3164280.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-4662000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxesReceivable_0_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-81489000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-24551000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":21688000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6648000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"EarningsPerShareDiluted_3_Q3_USD":-0.84,"EarningsPerShareDiluted_1_Q3_USD":-0.23,"EarningsPerShareBasic_3_Q3_USD":-0.84,"EarningsPerShareBasic_1_Q3_USD":-0.23,"Depreciation_3_Q3_USD":24000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-81503000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-24565000.0,"CommonStockValue_0_Q3_USD":104000.0,"CommonStockSharesOutstanding_0_Q3_shares":104237878.0,"CommonStockSharesIssued_0_Q3_shares":104237878.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":-1765000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":97370000.0,"Ticker":"ISEE","CIK":"1410939","name":"IVERIC BIO, INC.","OfficialName":"IVERIC bio Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1851737728.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]